论文部分内容阅读
AIM To investigate the real-world efficacy and safety of sofosbuvir/ribavirin(SOF/RBV)therapy for Japanese patients with genotype 2 hepatitis C virus(GT2-HCV).METHODS A total of 182 patients with GT2-HCV infection who received SOF/RBV therapy for 12 wk at